News & events

News & events

Filter by:
  • News

VarmX raises €30 million Series B2 financing for IND approval and preparations for pivotal trial

VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces it...
  • News

VarmX Appoints Dr. Jeffrey Lawson, MD, PhD as Chief Scientific Officer

VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces the...
  • News

VarmX raises seed capital for development of VMX-C001

VarmX, a Dutch, Leiden based biotech company focusing on the development of therapies in the field of hemostasis and...

VMX-C001: Transforming the treatment of bleeding in patients taking Factor Xa DOACs

Portfolio